D
Daniel J. Deziel
Researcher at Rush University Medical Center
Publications - 71
Citations - 5014
Daniel J. Deziel is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Cholecystectomy & Bile duct. The author has an hindex of 27, co-authored 68 publications receiving 4096 citations. Previous affiliations of Daniel J. Deziel include NewYork–Presbyterian Hospital & Rush Medical College.
Papers
More filters
Journal ArticleDOI
Complications of laparoscopic cholecystectomy: A national survey of 4,292 hospitals and an analysis of 77,604 cases
Daniel J. Deziel,Keith W. Millikan,Steven G. Economou,Alexander Doolas,Sung-Tao Ko,Mohan C. Airan +5 more
TL;DR: It is demonstrated that laparoscopic cholecystectomy is associated with low rates of morbidity and mortality but a significant rate of bile duct injury, which is significantly lower at institutions that had performed more than 100 cases.
Journal ArticleDOI
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).
Masamichi Yokoe,Jiro Hata,Tadahiro Takada,Steven M. Strasberg,Horacio J. Asbun,Go Wakabayashi,Kazuto Kozaka,Itaru Endo,Daniel J. Deziel,Fumihiko Miura,Kohji Okamoto,Tsann Long Hwang,Wayne Shih Wei Huang,Chen Guo Ker,Miin Fu Chen,Ho-Seong Han,Yoo Seok Yoon,In Seok Choi,Dong Sup Yoon,Yoshinori Noguchi,Satoru Shikata,Tomohiko Ukai,Ryota Higuchi,Toshifumi Gabata,Yasuhisa Mori,Yukio Iwashita,Taizo Hibi,Palepu Jagannath,Eduard Jonas,Kui Hin Liau,Christos Dervenis,Dirk J. Gouma,Daniel Cherqui,Giulio Belli,O. James Garden,Mariano E Giménez,Eduardo de Santibañes,Kenji Suzuki,Akiko Umezawa,Avinash Supe,Henry A. Pitt,Harjit Singh,Angus C.W. Chan,Wan Yee Lau,Anthony Yuen Bun Teoh,Goro Honda,Atsushi Sugioka,Koji Asai,Harumi Gomi,Takao Itoi,Seiki Kiriyama,Masahiro Yoshida,Toshihiko Mayumi,Naoki Matsumura,Hiromi Tokumura,Seigo Kitano,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +59 more
TL;DR: Thorough literature search about diagnostic criteria for acute cholecystitis, new and strong evidence that had been released from 2013 to 2017 was not found with serious and important issues about using TG13 diagnostic criteria of acute CholecyStitis, and the TG13 severity grading has been validated in numerous studies.
Journal ArticleDOI
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.
Kohji Okamoto,Kenji Suzuki,Tadahiro Takada,Steven M. Strasberg,Horacio J. Asbun,Itaru Endo,Yukio Iwashita,Taizo Hibi,Henry A. Pitt,Akiko Umezawa,Koji Asai,Ho-Seong Han,Tsann Long Hwang,Yasuhisa Mori,Yoo Seok Yoon,Wayne Shih Wei Huang,Giulio Belli,Christos Dervenis,Masamichi Yokoe,Seiki Kiriyama,Takao Itoi,Palepu Jagannath,O. James Garden,Fumihiko Miura,Masafumi Nakamura,Akihiko Horiguchi,Go Wakabayashi,Daniel Cherqui,Eduardo de Santibañes,Satoru Shikata,Yoshinori Noguchi,Tomohiko Ukai,Ryota Higuchi,Keita Wada,Goro Honda,Avinash Supe,Masahiro Yoshida,Toshihiko Mayumi,Dirk J. Gouma,Daniel J. Deziel,Kui Hin Liau,Miin Fu Chen,Kazunori Shibao,Keng Hao Liu,Cheng Hsi Su,Angus C.W. Chan,Dong Sup Yoon,In Seok Choi,Eduard Jonas,Xiao Ping Chen,Sheung Tat Fan,Chen Guo Ker,Mariano E Giménez,Seigo Kitano,Masafumi Inomata,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +58 more
TL;DR: In the Tokyo Guidelines 2018 (TG18) as discussed by the authors, the authors proposed a flowchart for the treatment of acute cholecystitis (AC) in advanced centers with specialized surgeons experienced in this procedure.
Journal ArticleDOI
Pyloric and gastric preserving pancreatic resection. Experience with 87 patients.
TL;DR: In most patients, long-term gastrointestinal function was judged to be excellent based on weight gain and lack of digestive symptoms, and cancer-free survival was comparable to that after the standard Whipple procedure.
Journal ArticleDOI
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Harumi Gomi,Joseph S. Solomkin,David Schlossberg,Kohji Okamoto,Tadahiro Takada,Steven M. Strasberg,Tomohiko Ukai,Itaru Endo,Yukio Iwashita,Taizo Hibi,Henry A. Pitt,Naohisa Matsunaga,Yoriyuki Takamori,Akiko Umezawa,Koji Asai,Kenji Suzuki,Ho-Seong Han,Tsann Long Hwang,Yasuhisa Mori,Yoo Seok Yoon,Wayne Shih Wei Huang,Giulio Belli,Christos Dervenis,Masamichi Yokoe,Seiki Kiriyama,Takao Itoi,Palepu Jagannath,O. James Garden,Fumihiko Miura,Eduardo de Santibañes,Satoru Shikata,Yoshinori Noguchi,Keita Wada,Goro Honda,Avinash Supe,Masahiro Yoshida,Toshihiko Mayumi,Dirk J. Gouma,Daniel J. Deziel,Kui Hin Liau,Miin Fu Chen,Keng Hao Liu,Cheng Hsi Su,Angus C.W. Chan,Dong Sup Yoon,In Seok Choi,Eduard Jonas,Xiao Ping Chen,Sheung Tat Fan,Chen Guo Ker,Mariano E Giménez,Seigo Kitano,Masafumi Inomata,Shuntaro Mukai,Ryota Higuchi,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +58 more
TL;DR: The Tokyo Guidelines 2018 provides recommendations for the appropriate use of antimicrobials for community‐acquired and healthcare‐associated infections and the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed.